
Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)
Author(s) -
Kathryn J. Ruddy,
Hao Guo,
William T. Barry,
Chau T. Dang,
Denise A. Yardley,
Beverly Moy,
P. Kelly Marcom,
Kathy S. Albain,
Hope S. Rugo,
Matthew J. Ellis,
Iuliana Shapira,
Antonio C. Wolff,
Lisa A. Carey,
Beth Overmoyer,
Clifford A. Hudis,
Ian E. Krop,
Harold J. Burstein,
Eric P. Winer,
Ann H. Partridge,
Sara M. Tolaney
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/e33z-ag80
Subject(s) - trastuzumab , paclitaxel , oncology , amenorrhea , adjuvant , medicine , chemotherapy , breast cancer , cancer , biology , pregnancy , genetics